Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (17054)	12/18/1998 5:43:00 PM
From: Mkilloran	Read Replies (2) \| Respond to of 23519

Vlad...we can look for the last of the tax selling to be completed in the next two weeks. Then we start the NEW YEAR.....looking for more shorts to cover in January as they carry over their profits into 1999 tax year. Looking for $8 million in milestone payments from Europe as Germany, Italy, Spain and France license Muse. Looking for a ramp up in production of Muse at the NJ factory to supply more Muse to the additional countries as they are being launched in 1999. Looking for Astra and Janssen to publish their pre and post Viagra script impact after Viagra is introduced in other countries. To confirm that Astra's and Janssen's marketing programs are working to recapture the customers that are not satisfied with Viagra as well as sales thru PCP's expand the use of Muse. Looking for a profitable 1st qtr 1999. Looking for a USA partnership with a marketing program modeled after Astra's and Janssen's to sell the safety factor of Muse and recapture the customers that were not satisfied with Viagra. Looking for continued progress on Alibra and announcement of distribution rights for Alibra worldwide with a target launch in year 2000. Looking for additional details to be published by Dr G Christ on Gene Therapy. Looking for the Amer College of Cartioligst to publish their report on Viagra in Jan. Looking for Janssen to launch more countries in South America, Asia, Africia, China... with additional $2 million milestone fee, etc. Looking for a partner to launch Muse in Japan. Looking for a better year in 1999 with Vivus returning to double digit stock prices as well as upgrades from Wall Street Analyst. Looking for ZONA and MCHM stock values to fall in 1999. As they are proven to be not effective treatments in the ED marketplace ...just as HVSF has fallen by the wayside in 1998.